Skip to main content

Table 1 Demographic Characteristics of the Sample

From: Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial

 

Placebo

MPH

p

n

10

10

 

Age (mean (sd))

31.00 (10.58)

31.50 (10.73)

0.918

Sex = Male (%)

2 (20.0)

3 (30.0)

1.000

Height (mean (sd))

65.78 (2.68)

66.50 (4.22)

0.666

Weight (mean (sd))

177.56 (50.33)

180.50 (30.93)

0.878

Race (%)

  

0.453

 Hispanic/Latino

0 (0.0)

1 (10.0)

 

 Native American

1 (10.0)

2 (20.0)

 

 White

9 (90.0)

7 (70.0)

 

Drug = MPH (%)

0 (0.0)

10 (100.0)

< 0.001

Current Smoker (%)

  

0.288

 Every-Day Smokers

2 (22.2)

0 (0.0)

 

 Former Smokers

2 (22.2)

3 (30.0)

 

 Never Smokers

5 (55.6)

7 (70.0)

 

Alcohol Use in last 30 days (mean (sd))

3.70 (9.30)

1.70 (2.79)

0.523

BMQ overuse (mean (sd))

12.50 (3.14)

11.80 (2.74)

0.602

BMQ general harm (mean (sd))

15.20 (2.10)

15.50 (2.07)

0.751

QIDS (mean (sd))

17.90 (2.73)

16.67 (2.12)

0.290